Adverse event profiles of dipeptidyl peptidase-4 inhibitors: data mining of the public version of the FDA adverse event reporting system

• Váldodahkkit: Jing Huang (Dahkki), Yuntao Jia (Dahkki), Shusen Sun (Dahkki), Long Meng (Dahkki)
• Materiálatiipa: Girji
• Almmustuhtton: BMC, 2020-09-01T00:00:00Z.
• Fáttát: article
• Liŋkkat: Connect to this object online.

Abstract Background To describe and analyze the patterns of adverse events associated with dipeptidyl peptidase-4 inhibitors (DPP-4is) (sitagliptin, saxagliptin, linagliptin, vildagliptin, and alogliptin) from the FDA Adverse Event Reporting System (FAERS) and to highlight areas of safety concerns....